Lars Bevanger

1.1k total citations
33 papers, 942 citations indexed

About

Lars Bevanger is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Epidemiology. According to data from OpenAlex, Lars Bevanger has authored 33 papers receiving a total of 942 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Public Health, Environmental and Occupational Health, 12 papers in Infectious Diseases and 11 papers in Epidemiology. Recurrent topics in Lars Bevanger's work include Neonatal and Maternal Infections (18 papers), Streptococcal Infections and Treatments (17 papers) and Pneumonia and Respiratory Infections (9 papers). Lars Bevanger is often cited by papers focused on Neonatal and Maternal Infections (18 papers), Streptococcal Infections and Treatments (17 papers) and Pneumonia and Respiratory Infections (9 papers). Lars Bevanger collaborates with scholars based in Norway, Sweden and Poland. Lars Bevanger's co-authors include Kåre Bergh, Jan Egil Afset, Peter Gaustad, Asbjørn Digranes, Hanne H. Haukland, Per Sandven, Pål Romundstad, Ole‐Jan Iversen, Turid Mannsåker and Josée Harel and has published in prestigious journals such as Journal of Clinical Microbiology, Advances in experimental medicine and biology and International Journal of Antimicrobial Agents.

In The Last Decade

Lars Bevanger

33 papers receiving 888 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Bevanger Norway 17 536 385 338 303 118 33 942
M Jahkola Finland 13 333 0.6× 266 0.7× 289 0.9× 234 0.8× 274 2.3× 25 939
A. Cody Springman United States 11 292 0.5× 298 0.8× 462 1.4× 365 1.2× 154 1.3× 12 1.1k
Haima Mylvaganam Norway 16 537 1.0× 183 0.5× 441 1.3× 195 0.6× 81 0.7× 41 889
Monorama Deb India 20 347 0.6× 331 0.9× 231 0.7× 190 0.6× 166 1.4× 38 941
J. Pita Spain 16 235 0.4× 306 0.8× 224 0.7× 249 0.8× 141 1.2× 18 797
P. Mariani-Kurkdjian France 15 450 0.8× 153 0.4× 103 0.3× 489 1.6× 175 1.5× 45 899
J.L. Gómez‐Garcés Spain 14 150 0.3× 266 0.7× 146 0.4× 106 0.3× 56 0.5× 29 532
Céline Plainvert France 17 284 0.5× 343 0.9× 611 1.8× 131 0.4× 35 0.3× 45 896
M Deb India 16 196 0.4× 293 0.8× 93 0.3× 121 0.4× 122 1.0× 49 695
M. J. Zervos United States 13 643 1.2× 310 0.8× 213 0.6× 68 0.2× 113 1.0× 15 922

Countries citing papers authored by Lars Bevanger

Since Specialization
Citations

This map shows the geographic impact of Lars Bevanger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Bevanger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Bevanger more than expected).

Fields of papers citing papers by Lars Bevanger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Bevanger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Bevanger. The network helps show where Lars Bevanger may publish in the future.

Co-authorship network of co-authors of Lars Bevanger

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Bevanger. A scholar is included among the top collaborators of Lars Bevanger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Bevanger. Lars Bevanger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Afset, Jan Egil, Guillaume Bruant, Roland Brousseau, et al.. (2006). Identification of Virulence Genes Linked with Diarrhea Due to Atypical Enteropathogenic Escherichia coli by DNA Microarray Analysis and PCR. Journal of Clinical Microbiology. 44(10). 3703–3711. 120 indexed citations
2.
Sandven, Per, Lars Bevanger, Asbjørn Digranes, et al.. (2006). Candidemia in Norway (1991 to 2003): Results from a Nationwide Study. Journal of Clinical Microbiology. 44(6). 1977–1981. 148 indexed citations
3.
Stenström, Björn, Kirsti Løseth, Lars Bevanger, et al.. (2005). Gastric bypass surgery does not increase susceptibility to Helicobacter pylori infection in the stomach of rat or mouse. Inflammopharmacology. 13(1-3). 229–234. 7 indexed citations
4.
Simonsen, Gunnar Skov, Kåre Bergh, Lars Bevanger, et al.. (2004). Susceptibility to quinupristin-dalfopristin and linezolid in 839 clinical isolates of gram-positive cocci from Norway. Scandinavian Journal of Infectious Diseases. 36(4). 254–258. 5 indexed citations
5.
Afset, Jan Egil, Lars Bevanger, Pål Romundstad, & Kåre Bergh. (2004). Association of atypical enteropathogenic Escherichia coli (EPEC) with prolonged diarrhoea. Journal of Medical Microbiology. 53(11). 1137–1144. 112 indexed citations
6.
Leegaard, Truls Michael, Lars Bevanger, Roland Jureen, et al.. (2001). Antibiotic sensitivity still prevails in Norwegian blood culture isolates. International Journal of Antimicrobial Agents. 18(2). 99–106. 11 indexed citations
7.
Radtke, Andreas, Kåre Bergh, Cecilia Montgomery Øien, & Lars Bevanger. (2001). Peritoneal Dialysis-Associated Peritonitis Caused by Dermabacter hominis. Journal of Clinical Microbiology. 39(9). 3420–3421. 17 indexed citations
8.
Moyo, Sylvester R., Johan A. Mæland, & Lars Bevanger. (1999). Comparison of three different methods in monoclonal antibody‐based detection of Streptococcus agalactiae protein serotype markers. Apmis. 107(1-6). 263–269. 12 indexed citations
9.
Mæland, Johan A., et al.. (1999). bca , Beta Gene, and Gene Product Divergency in Reference and Prototype Strains of Streptococcus agalactiae. Clinical and Diagnostic Laboratory Immunology. 6(6). 986–988. 4 indexed citations
10.
Bevanger, Lars, et al.. (1997). An Apparently New Strain-Variable Streptococcus agalactiae Protein. Advances in experimental medicine and biology. 418. 355–357. 4 indexed citations
11.
Bevanger, Lars, et al.. (1997). Aberrations in Expression of the β Antigen of Streptococcus agalactiae. Advances in experimental medicine and biology. 418. 999–1001. 1 indexed citations
12.
Bevanger, Lars, et al.. (1995). A Streptococcus agalactiae R protein analysed by polyclonal and monoclonal antibodies. Apmis. 103(7-8). 731–736. 22 indexed citations
13.
Mæland, Johan A., et al.. (1993). Serological testing for campylobacteriosis with sera forwarded for Salmonella and Yersinia serology. Apmis. 101(7-12). 647–650. 3 indexed citations
14.
Bevanger, Lars, et al.. (1992). Characterization of the a antigen of the c proteins of group B streptococci (GBS) using a murine monoclonal antibody. Apmis. 100(1-6). 57–62. 19 indexed citations
15.
Iversen, Ole‐Jan, et al.. (1992). Binding of human IgA to HCl‐extracted c protein from group B streptococci (GBS). Apmis. 100(7-12). 1129–1132. 1 indexed citations
16.
Bevanger, Lars, et al.. (1991). Evaluation of monoclonal antibodies in serovar classification of group B streptococci (GBS). Apmis. 99(7-12). 1058–1060. 13 indexed citations
17.
Bevanger, Lars. (1985). The Ibc Proteins Of Group b Streptococci: Isolation Of The α and β Antigens by Immunosorbent Chromatography and Test For Human Serum Antibodies Against The Two Antigens. Acta Pathologica Microbiologica Scandinavica Series B Microbiology. 93B(1-6). 113–119. 17 indexed citations
18.
Bevanger, Lars. (1983). Ibc PROTEINS AS SEROTYPE MARKERS OF GROUP B STREPTOCOCCI. Acta Pathologica Microbiologica Scandinavica Series B Microbiology. 91B(1-6). 231–234. 39 indexed citations
19.
Bevanger, Lars, et al.. (1979). Complete And Incomplete Ibc Protein Fraction in Group B Streptococci. Acta Pathologica Microbiologica Scandinavica Section B Microbiology. 87B(1-6). 51–54. 42 indexed citations
20.
Bevanger, Lars. (1976). YERSINIA PSEUDOTUBERCULOSIS AS THE CAUSE OF SEPTICAEMIA IN A PATIENT WITH AMYLOIDOSIS. Acta Pathologica Microbiologica Scandinavica Section B Microbiology. 84B(6). 461–462. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Jahkola Breakdown of academic impact, for papers by A. Cody Springman Breakdown of academic impact, for papers by Haima Mylvaganam Breakdown of academic impact, for papers by Monorama Deb Breakdown of academic impact, for papers by J. Pita Breakdown of academic impact, for papers by P. Mariani-Kurkdjian Breakdown of academic impact, for papers by J.L. Gómez‐Garcés Breakdown of academic impact, for papers by Céline Plainvert Breakdown of academic impact, for papers by M Deb Breakdown of academic impact, for papers by M. J. Zervos
Rankless by CCL
2026